HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Contraceptive potential of a mifepristone-nomegestrol acetate sequential regimen in women.

Abstract
The effectiveness of a sequential regimen consisting of mifepristone, 10 mg/day for 15 days, followed by nomegestrol acetate (NOMA), 5 mg/day for the next 13 days, for inhibiting ovulation and maintaining regular bleeding cycles was assessed in 10 surgically sterilized volunteers who were followed for one pretreatment and three treated cycles. Hormonal determinations in blood and urine, ovarian ultrasonography, bleeding records in all cycles and an endometrial biopsy taken on day 22-25 of the third treatment cycle were used to monitor the effects of treatment. During treatment, 24 monophasic (no sustained progesterone rise above 12 nmol/l) and six biphasic cycles were recorded. Nine follicular ruptures were detected echographically in these 30 treated cycles, five of which occurred in monophasic cycles. All follicular ruptures occurred on days 1-7 of NOMA treatment. Echographic and endocrine features of ovulatory cycles were both present in only four treated cycles (13.3%). Development of a secretory endometrium was achieved in all cases, but it was always irregular. Regular withdrawal bleeding occurred in all subjects and no adverse reactions were recorded. The ovarian and endometrial effects of this regimen justify testing its contraceptive effectiveness in phase 2 clinical trials.
AuthorsH B Croxatto, A M Salvatierra, B Fuentealba, R Massai
JournalHuman reproduction (Oxford, England) (Hum Reprod) Vol. 13 Issue 12 Pg. 3297-302 (Dec 1998) ISSN: 0268-1161 [Print] England
PMID9886502 (Publication Type: Clinical Trial, Clinical Trial, Phase I, Journal Article, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, Non-P.H.S.)
Chemical References
  • Contraceptives, Oral, Combined
  • Menstruation-Inducing Agents
  • Norpregnadienes
  • Progesterone Congeners
  • Mifepristone
  • Progesterone
  • Estradiol
  • nomegestrol acetate
  • Luteinizing Hormone
  • Megestrol
Topics
  • Adult
  • Contraceptives, Oral, Combined (administration & dosage)
  • Estradiol (blood)
  • Female
  • Humans
  • Luteinizing Hormone (urine)
  • Megestrol
  • Menstruation-Inducing Agents (administration & dosage)
  • Mifepristone (administration & dosage)
  • Norpregnadienes (administration & dosage)
  • Ovulation (drug effects)
  • Progesterone (blood)
  • Progesterone Congeners (administration & dosage)
  • Sterilization, Reproductive

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: